247 related articles for article (PubMed ID: 15859941)
1. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures.
Oliveira VD; Zankl H; Rath T
Exp Clin Transplant; 2004 Dec; 2(2):273-9. PubMed ID: 15859941
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
Waller JR; Brook NR; Bicknell GR; Murphy GJ; Nicholson ML
Transplant Proc; 2005; 37(1):164-6. PubMed ID: 15808582
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of immunosuppressive medications among renal transplant recipients.
Rath T; Oliveira-Frick V
Am J Nephrol; 2009; 30(6):514-20. PubMed ID: 19816013
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells.
Cilião HL; Ribeiro DL; Camargo-Godoy RB; Specian AF; Serpeloni JM; Cólus IM
Exp Toxicol Pathol; 2015 Feb; 67(2):179-87. PubMed ID: 25541063
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
Kyles AE; Gregory CR; Craigmill AL
Am J Vet Res; 2000 Aug; 61(8):906-9. PubMed ID: 10951980
[TBL] [Abstract][Full Text] [Related]
6. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF
J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
Heidt S; Roelen DL; Eijsink C; van Kooten C; Claas FH; Mulder A
Transplantation; 2008 Nov; 86(9):1292-300. PubMed ID: 19005412
[TBL] [Abstract][Full Text] [Related]
8. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
Powell N; Till S; Bungre J; Corrigan C
J Allergy Clin Immunol; 2001 Dec; 108(6):915-7. PubMed ID: 11742267
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil pharmacokinetics in transplant patients receiving cyclosporine or tacrolimus in combination therapy.
Vidal E; Cantarell C; Capdevila L; Monforte V; Roman A; Pou L
Pharmacol Toxicol; 2000 Oct; 87(4):182-4. PubMed ID: 11097273
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function.
Jeanmart H; Malo O; Carrier M; Nickner C; Desjardins N; Perrault LP
J Heart Lung Transplant; 2002 Sep; 21(9):990-8. PubMed ID: 12231370
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine.
Vacher-Coponat H; Brunet C; Moal V; Loundou A; Bonnet E; Lyonnet L; Ravet S; Sampol-Manos E; Sampol J; Berland Y; George FD; Paul P
Transplantation; 2006 Aug; 82(4):558-66. PubMed ID: 16926601
[TBL] [Abstract][Full Text] [Related]
12. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro.
Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.
Picard N; Prémaud A; Rousseau A; Le Meur Y; Marquet P
Br J Clin Pharmacol; 2006 Oct; 62(4):477-84. PubMed ID: 16995869
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
[TBL] [Abstract][Full Text] [Related]
16. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
[TBL] [Abstract][Full Text] [Related]
17. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
18. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
ten Berge RJ; Schellekens PT
Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.
Oz HS; Hughes WT
J Infect Dis; 1997 Apr; 175(4):901-4. PubMed ID: 9086147
[TBL] [Abstract][Full Text] [Related]
20. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Azzola A; Havryk A; Chhajed P; Hostettler K; Black J; Johnson P; Roth M; Glanville A; Tamm M
Transplantation; 2004 Jan; 77(2):275-80. PubMed ID: 14742993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
